FBLN4 anticorps (Middle Region)
Aperçu rapide pour FBLN4 anticorps (Middle Region) (ABIN633884)
Antigène
Voir toutes FBLN4 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- Middle Region
-
Specificité
- EFEMP2 antibody was raised against the middle region of EFEMP2
-
Purification
- Affinity purified
-
Immunogène
- EFEMP2 antibody was raised using the middle region of EFEMP2 corresponding to a region with amino acids VSAMLVLARPVTGPREYVLDLEMVTMNSLMSYRASSVLRLTVFVGAYTF
-
-
-
-
Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
EFEMP2 Blocking Peptide, (ABIN5613312), is also available for use as a blocking control in assays to test for specificity of this EFEMP2 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of EFEMP2 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- FBLN4 (Fibulin 4 (FBLN4))
-
Autre désignation
- EFEMP2
-
Sujet
- A large number of extracellular matrix proteins have been found to contain variations of the epidermal growth factor (EGF) domain and have been implicated in functions as diverse as blood coagulation and activation of complement.
-
Poids moléculaire
- 49 kDa (MW of target protein)
Antigène
-